ArticleESMO gastrointestinal oncology2025

Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping.

J Sgouros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.